DCM Shriram Recommends 200% Final Dividend & Approves ₹101 Crore HSCL Investment
DCM Shriram's board approved audited financial results for the year ended March 31, 2026, and recommended a final dividend of ₹4 per share. Total dividend for FY26 would be ₹11.20 per share including interim dividends. The 37th AGM is scheduled for 18th August 2026. The board approved a ₹101 crore capital expenditure plan for Hindusthan Specialty Chemicals Ltd (HSCL) and financial assistance of up to ₹100 crore.
The dividend announcement and investment plans are likely to have a moderate positive impact on investor sentiment and the company's future prospects.
The announcement includes positive elements such as dividend declaration, approval of financial results, and investment plans for subsidiary, indicating potential growth and returns for investors.
The Board of Directors of DCM Shriram Limited, in its meeting on 13th May 2026, approved the audited financial results (both standalone and consolidated) for the quarter and financial year ended 31st March 2026. The board recommended a final dividend of 200%, i.e., ₹4 per equity share of face value ₹2 each, subject to shareholder approval at the 37th Annual General Meeting (AGM). If approved, the total dividend for FY26 would be ₹11.20 per share, including two interim dividends of ₹3.60 each already declared. The final dividend will be paid within 30 days from the AGM date. 37th AGM of the shareholders of the Company will be convened on Tuesday, 18th August 2026. The board also considered and approved, subject to shareholder approval, the cancellation of 39,00,000 forfeited equity shares of the company. The aggregate amount paid-up on such forfeited shares is ₹15.60 lakhs. The Board has also approved capital expenditure plan of Hindusthan Specialty Chemicals Ltd (HSCL), a wholly owned subsidiary, with investment of ₹101 crores to increase Formulated Resins (FR) capacity by 36K TPA reaching a total of 50K TPA and approved financial assistance to HSCL of upto ₹100 crores through a mix of Equity & Debt.
The Board meeting commenced on 13th May 2026 at 11:00 A.M. and concluded at 5:15 P.M.
Deloitte Haskins & Sells, Chartered Accountants, have issued an unmodified opinion on the standalone financial results for the year ended March 31, 2026.
What to do with a filing like this
DCM Shriram Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by DCM Shriram Limited. Read the original for the full detail.